CDMC 2018: Shifting gears in the management of diabetes and CVD
Meeting report of the Cardio Diabetes Master Class (CDMC) held in november 2018 in Dubai, UAE as an educational service for participants with video and slides. The Cardio Diabetes Master Class is an initiative of PACE-CME
Episodes 1-12 of 12
- CDMC 2018: Shifting gears in the management of diabetes and CVDTwo choices of drugs that reduce CV risk in T2DM
Prof. John Deanfield, MD
- CDMC 2018: Shifting gears in the management of diabetes and CVDTranslating mechanisms of GLP-1RAs and SGLT2 inhibitors to CV benefits
Dr. Adie Viljoen, MD
- CDMC 2018: Shifting gears in the management of diabetes and CVDBenefits of GLP-1RA and SGLT2-i in primary and secondary prevention of CVD in T2DM
Prof. Eduard Montanya, MD
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Screening for Diabetes: When is it meaningful and how should it be performed
Prof. Lars Rydén
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
Prof. Richard Hobbs, MD
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: The GLP1 landscape - refining our understanding
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Shifting gears in CVD & T2DM: What is the rationale for new diabetes interventions in the course of CVD?
Prof John E Deanfield
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Diabetes: The new challenge in cardiovascular risk management
Prof. Lars Rydén
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Translating mechanisms to benefits: How can we explain the cardiovascular benefits of new diabetes drugs?
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Clinical trials in T2DM & CVD: Review of key outcomes with GLP-1 RA and SGLT2i
Prof. Eduard Montanya Barcelona
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: The clinical landscape for T2DM and CVD: impact on guidelines and practice
Prof John E Deanfield
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Targeting CV risk: Implications for clinical management of patients with T2DM & CVD
Prof. Richard Hobbs, MD
